Recalls for 06/28/2013

Medtronic SynchroMed Implantable Infusion System Devices: Class 1 Recalls - Feed Through Failure, Failure of Priming Bolus, and Catheter Occlusion
06/28/2013 Medical Recall

Medtronic SynchroMed II and SynchroMed EL Implantable Drug Infusion Pumps and Sutureless Connector Intrathecal Catheter Products Recalled.

  • Company:
    Medtronic
Medtronic Issues Medical Device Notifications Regarding The Synchromed Implantable Infusion System
06/28/2013 Food Recall

June 26, 2013 - MINNEAPOLIS – In June 2013, Medtronic, Inc. (NYSE: MDT) initiated four medical device notifications to customers worldwide about the SynchroMed Implantable Infusion System. These notifications provide clinicians with information to help identify and manage issues that impact the safe and reliable delivery of therapy using the SynchroMed Implantable Infusion System.

  • Company:
    Medtronic, Inc.
  • Problem
    Undeclared Milk, Soy And Wheat
JaDera and Xiyouji Qingzhi Dietary Supplements by Dolphin Intertrade Corp.: Recall - Undeclared Drug Ingredient
06/28/2013 Medical Recall

Products have been found to contain undeclared Sibutramine, known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

  • Company:
    Dolphin Intertrade Corp.
Dolphin Intertrade Corp
06/28/2013 Food Recall

Miami, Florida Dolphin Intertrade Corp. is voluntary recalling “JaDera” and “Xiyouji Qingzhi” Weight Loss Supplement. These product have been found to contain undeclared Sibutramine, Sibutramine was a previously approved controlled substance for the treatment of obesity that was removed from the U.S. market in October 2010 for safety reasons, making this product an unapproved new drug.

  • Company:
    Dolphin Intertrade Corp
  • Problem
    Entanglement Hazard